Kevin McCaffrey

Most Recent Articles by Kevin McCaffrey

Five things for pharma marketers to know: Monday, October 16, 2017

Five things for pharma marketers to know: Monday, October 16, 2017

By

FDA briefing document affirms diabetes drug's efficacy; J&J debuts new tools to improve adherence; AZ says cancer drug data was falsified

Five things for pharma marketers to know: Friday, October 13, 2017

Five things for pharma marketers to know: Friday, October 13, 2017

By

Outcome Health reportedly misled advertisers; FDA committee recommends gene therapy; Avanir drug is highly prescribed by docs paid by company

Five things for pharma marketers to know: Wednesday, October 4, 2017

Five things for pharma marketers to know: Wednesday, October 4, 2017

By

The FDA approves Mylan's Copaxone generic; 3 out of every 1,000 Americans face $50,000 in drug costs; some ACA premiums may rise by 50%

Five things for pharma marketers to know: Tuesday, October 3, 2017

Five things for pharma marketers to know: Tuesday, October 3, 2017

By

The FDA wants to improve the generic drug approval process; Allergan CEO responds to criticism of patent deal; breast cancer death rate dropped 40%

Five things for pharma marketers to know: Monday, October 2, 2017

Five things for pharma marketers to know: Monday, October 2, 2017

By

The FDA tells 75 opioid drugmakers to fund training efforts; epilepsy drug reduces seizure frequency; FDA approves Novo's fast-acting mealtime insulin

More Articles by Kevin McCaffrey